Raghvendra M. Srivastava

Genetic diversity of tumors with mismatch repair deficiency influences anti–PD-1 immunotherapy response

Rajarsi Mandal, Robert Samstein, Ken-Wing Lee et al. · Science · 2019 · 578 citations · Full text

Life Sciences, Immunology, Oncology +17

Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy

Chirag Krishna, Renzo G. DiNatale, Fengshen Kuo et al. · Cancer Cell · 2021 · 439 citations · Full text

Medicine, Immunology, Oncology +16

Immunogenic neoantigens derived from gene fusions stimulate T cell responses

Wei Yang, Ken-Wing Lee, Raghvendra M. Srivastava et al. · Nature Medicine · 2019 · 382 citations

Life Sciences, Immunology, Molecular Biology +16

Identification of the Cell-Intrinsic and -Extrinsic Pathways Downstream of EGFR and IFNγ That Induce PD-L1 Expression in Head and Neck Cancer

Fernando Concha‐Benavente, Raghvendra M. Srivastava, Sumita Trivedi et al. · Cancer Research · 2015 · 302 citations · Full text

Medicine, Cancer Biology, Oncology +17

PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer

Benjamin Kansy, Fernando Concha‐Benavente, Raghvendra M. Srivastava et al. · Cancer Research · 2017 · 252 citations · Full text

Life Sciences, Immunology, Oncology +17